ICB International
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
505 Coast Blvd S Ste 405, La Jolla, Cali...Phone Number
(858) 455-9880Website
www.icbii.comRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About ICB International
ICBI specializes in developing breakthrough therapeutic drugs using its proprietary SMART Molecule Technology Platform, which enables the delivery of treatments across the blood-brain barrier for neurodegenerative disorders like Alzheimer's and Parkinson's disease. The company aims to address the needs of the 65 million individuals globally affected by these diseases, with a focus on early diagnosis, monitoring, and treatment. ICBI's innovative biologics target pathological proteins in the central nervous system, offering significant clinical potential. Established in 2008, ICBI has garnered respect in the scientific community through extensive research and numerous patents.Explore more
ICB International Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ICB International your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on ICB International recently announced quarterly report
Check out if ICB International is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at ICB International
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when ICB International launches new products
Check if ICB International has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once ICB International has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
ICB International, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if ICB International had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to ICB International
Compare insights from companies similar to ICB International, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ICB International is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ICB International is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ICB International.
ICB International financials insights
Gather financial insights about ICB International, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$52K
ICB International Tech Stack
A closer look at the technologies used by ICB International
ICB International News & Media
A Biotech Company, ICBII launching Digital Securities on the Tokenization Asset Platform
Tokenization Asset Platform (TAP) is delighted to announce that ICBII, a California-based pharmaceutical company, plans to tokenize & launch digital securities NEW YORK, UNITED STATES, August 17, 2021 /EINPresswire.com/ -- Tokenization Asset …ICBII Announces the Approval of its latest patent on Blood-Brain Barrier Permeable Technology accelerating the company's progress towards treating Neuro-Degenerative Alzheimer's and Parkinson's Diseases.
Innovative California Biosciences International, Inc., ("ICBII"), announced on April 15th the approval of its patent for Blood-Brain Barrier (BBB) Permeable Peptide Composition. This is ICBII's 6th US and international patent, further validating the unique capability of ICBII's SMART molecules in overcoming the age-old BBB problem in treating diseases of the brain. Estimated 98% of all drugs cannot cross the BBB. The ones that do cross the BBB only provide short-term symptomatic relief without aICBII Announces the Filing of Orphan Drug Designation Application for the Use of α-Synuclein-SMART Molecule in the Treatment of Multiple System Atrophy
LA JOLLA, Calif., Dec. 5, 2017 /PRNewswire/ -- Innovative California Biosciences International, Inc., ("ICBII"), announced on November 20th the submission of their Orphan Drug Designation application to the US Food and Drug Administration (FDA) for the use of α-synuclein-SMART Molecule...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ICB International
Sign Up For FreeTo access detailed company insights
ICBI specializes in developing breakthrough therapeutic drugs using its proprietary SMART Molecule Technology Platform, which enables the delivery of treatments across the blood-brain barrier for neurodegenerative disorders like Alzheimer's and Parkinson's disease. The company aims to address the needs of the 65 million individuals globally affecte... Read More
